CORT FY 2018 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$251M+57.8% YoY

Gross Profit

$246M97.9% margin

Operating Income

$89M35.6% margin

Net Income

$75M30.0% margin

EPS (Diluted)

$0.60

Cash Flow

Operating Cash Flow

$116M

Free Cash Flow

$115M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$312M

Total Liabilities

$36M

Stockholders' Equity

$276M

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$251M	$159M	+57.8%
Gross Profit	$246M	$156M	+58.1%
Operating Income	$89M	$53M	+69.3%
Net Income	$75M	$129M	-41.6%